The previous page is sending you to https://globenewswire.com/news-release/2017/04/24/970522/0/en/Novartis-expands-global-collaboration-with-Amgen-to-commercialize-first-in-class-AMG-334-erenumab-program-in-migraine-prevention-in-the-US-and-Canada.html.

 If you do not want to visit that page, you can return to the previous page.